← Eichor
Study identifier: NCT03312556 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Treatment of Supine Hypertension in Autonomic Failure (CPAP)

Condition: Supine Hypertension · Autonomic Failure  ·  Sponsor: Vanderbilt University Medical Center

PhaseNA
Planned participants12
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

Supine hypertension is a common problem that affects at least 50% of patients with primary autonomic failure. Supine hypertension can be severe and complicates the treatment of orthostatic hypotension. The purpose of this study is to assess whether continuous positive airway pressure (CPAP) decreases blood pressure in autonomic failure patients with supine hypertension.

This description comes directly from the study's public registry record.

Talk to the study team

Bonnie K Black, RN  ·  615-343-6862  ·  autonomics@vumc.org

Luis E Okamoto, MD  ·  (615) 936-6119  ·  autonomics@vumc.org

Always discuss trial participation with your own doctor first.

Locations (1)

Autonomic Dysfunction Center/ Vanderbilt University Medical CenterNashville, Tennessee, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03312556